- New options are emerging for people who are at risk of heart attacks and strokes but can't take or benefit fully from widely used cholesterol drugs.
- A daily pill, bempedoic acid, significantly reduced the risk of heart attacks, strokes and other cardiovascular complications in people intolerant of statins.
- Nexletol and Nexlizet, which combine bempedoic acid with another nonstatin cholesterol-lowering drug, ezetimibe, are on the market.
- Merck & Co. said Monday that it is making progress on a potential new PCSK9 inhibitor.
- Another study showed that an anti-inflammatory drug called colchicine lowered cardiovascular risk in patients on statins with heart disease.
Alternatives to Popular Cholesterol-Lowering Drug Cut Heart-Attack Risk
New options for patients at risk of heart attacks and strokes who can't take or benefit fully from widely used cholesterol drugs are emerging. Bempedoic acid, Nexletol and Nexlizet, and an anti-inflammatory drug were found to reduce cardiovascular risk.